Sara Ek
21 – 40 of 60
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia
(
- Contribution to journal › Article
- 2017
-
Mark
Frequency and clinical implications of SOX11 expression in Burkitt lymphoma
(
- Contribution to journal › Letter
-
Mark
Crosstalk between ROR1 and BCR pathways defines novel treatment strategies in mantle cell lymphoma.
(
- Contribution to journal › Article
-
Mark
Genome-Wide DNA Methylation Profiling of Chronic Lymphocytic Leukemia Subsets Carrying Stereotyped B Cell Receptors
(
- Contribution to journal › Published meeting abstract
-
Mark
TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy
(
- Contribution to journal › Article
- 2016
-
Mark
SOX11 and HIG-2 are cross-regulated and affect growth in mantle cell lymphoma.
2016) In Leukemia & Lymphoma(
- Contribution to journal › Article
-
Mark
Identification of V-ATPase as a molecular sensor of SOX11-levels and potential therapeutic target for mantle cell lymphoma
(
- Contribution to journal › Article
- 2015
-
Mark
Emerging role of SOX11 in mantle cell lymphoma
(
- Contribution to journal › Scientific review
- 2014
-
Mark
SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma - a Nordic Lymphoma Group study.
(
- Contribution to journal › Article
- 2013
-
Mark
Nuclear T-STAR Protein Expression Correlates with HER2 Status, Hormone Receptor Negativity and Prolonged Recurrence Free Survival in Primary Breast Cancer and Decreased Cancer Cell Growth In Vitro.
(
- Contribution to journal › Article
-
Mark
Protein Expression Profiling of Formalin-Fixed Paraffin-Embedded Tissue Using Recombinant Antibody Microarrays
(
- Contribution to journal › Article
- 2012
-
Mark
Expanded clinical and experimental use of SOX11-using a monoclonal antibody
(
- Contribution to journal › Article
- 2011
-
Mark
The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation
(
- Contribution to journal › Article
-
Mark
Surrogate antigens as targets for proteome-wide binder selection
(
- Contribution to journal › Article
-
Mark
Knock-down of SOX11 induces autotaxin-dependent increase in proliferation in vitro and more aggressive tumors in vivo
(
- Contribution to journal › Article
-
Mark
Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases.
(
- Contribution to journal › Article
- 2010
-
Mark
Identification of uniquely expressed transcription factors in highly purified B-cell lymphoma samples.
(
- Contribution to journal › Article
-
Mark
SOX11 expression correlates to promoter methylatuion and regulates tumor growth in hematopoietic malignancies
(
- Contribution to journal › Article
- 2009
-
Mark
The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer
(
- Contribution to journal › Article
-
Mark
Identification of molecular targets associated with transformed diffuse large B cell lymphoma using highly purified tumor cells.
(
- Contribution to journal › Article